Ekso Bionics Holdings (LTS:0IFR) ROE % Adjusted to Book Value : -35.99% (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ekso Bionics Holdings ROE % Adjusted to Book Value?

Ekso Bionics Holdings's ROE % for the quarter that ended in Sep. 2024 was -61.55%. Ekso Bionics Holdings's PB Ratio for the quarter that ended in Sep. 2024 was 1.71. Ekso Bionics Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -35.99%.

Ekso Bionics Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Ekso Bionics Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings ROE % Adjusted to Book Value Chart

Ekso Bionics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-32.79

-22.78

-46.42

-54.08

-26.45

Ekso Bionics Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-123.36	-30.56	-59.83	-47.15	-35.99

Competitive Comparison of Ekso Bionics Holdings's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ekso Bionics Holdings's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's ROE % Adjusted to Book Value falls into.

Ekso Bionics Holdings ROE % Adjusted to Book Value Calculation

Ekso Bionics Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-79.89%	/	3.02
	=	-26.45%

Ekso Bionics Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-61.55%	/	1.71
	=	-35.99%

Ekso Bionics Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ekso Bionics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (LTS:0IFR) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

EKSO:USA 23E2:Germany

Address

101 Glacier Point, Suite A, San Rafael, CA, USA, 94901

Website

https://www.eksobionics.com

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings Headlines

No Headlines